SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Adnavance Technologies Inc. Meets Development Milestone for New Direct Detection MRSA Diagnostic Test; Triggers $1.8 Million in Second Tranche of Series B Financing